These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1391975)
21. Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers. Purrington KS; Gorski D; Simon MS; Hastert TA; Kim S; Rosati R; Schwartz AG; Ratnam M Breast Cancer Res Treat; 2020 May; 181(1):145-154. PubMed ID: 32236827 [TBL] [Abstract][Full Text] [Related]
22. Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. Satariano ER; Swanson GM; Moll PP Am J Public Health; 1992 Feb; 82(2):195-8. PubMed ID: 1739146 [TBL] [Abstract][Full Text] [Related]
23. Descriptive epidemiology of prostate cancer in metropolitan Detroit. Taylor JD; Holmes TM; Swanson GM Cancer; 1994 Mar; 73(6):1704-7. PubMed ID: 8156498 [TBL] [Abstract][Full Text] [Related]
24. Male breast cancer: a 22-year experience. Yildirim E; Berberoğlu U Eur J Surg Oncol; 1998 Dec; 24(6):548-52. PubMed ID: 9870732 [TBL] [Abstract][Full Text] [Related]
25. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Lantz PM; Mujahid M; Schwartz K; Janz NK; Fagerlin A; Salem B; Liu L; Deapen D; Katz SJ Am J Public Health; 2006 Dec; 96(12):2173-8. PubMed ID: 17077391 [TBL] [Abstract][Full Text] [Related]
26. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage. Madison T; Schottenfeld D; Baker V Cancer; 1998 Oct; 83(8):1546-54. PubMed ID: 9781948 [TBL] [Abstract][Full Text] [Related]
27. Race and ethnicity and breast cancer outcomes in an underinsured population. Komenaka IK; Martinez ME; Pennington RE; Hsu CH; Clare SE; Thompson PA; Murphy C; Zork NM; Goulet RJ J Natl Cancer Inst; 2010 Aug; 102(15):1178-87. PubMed ID: 20574040 [TBL] [Abstract][Full Text] [Related]
28. Racial differences in cervical cancer survival in the Detroit metropolitan area. Movva S; Noone AM; Banerjee M; Patel DA; Schwartz K; Yee CL; Simon MS Cancer; 2008 Mar; 112(6):1264-71. PubMed ID: 18257090 [TBL] [Abstract][Full Text] [Related]
29. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database. Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365 [TBL] [Abstract][Full Text] [Related]
30. Racial disparities in treatment and survival of male breast cancer. Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572 [TBL] [Abstract][Full Text] [Related]
31. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system. Jatoi I; Becher H; Leake CR Cancer; 2003 Sep; 98(5):894-9. PubMed ID: 12942554 [TBL] [Abstract][Full Text] [Related]
32. Impact of breast carcinoma on African-American women: the Detroit experience. Newman LA; Carolin K; Simon M; Kosir M; Hyrniuk W; Demers R; Grossbart Schwartz A; Visscher D; Peters W; Bouwman D Cancer; 2001 May; 91(9):1834-43. PubMed ID: 11335911 [TBL] [Abstract][Full Text] [Related]
33. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994. Schwartz KL; Severson RK; Gurney JG; Montie JE Cancer; 1996 Sep; 78(6):1260-6. PubMed ID: 8826949 [TBL] [Abstract][Full Text] [Related]
34. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival. Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656 [TBL] [Abstract][Full Text] [Related]
35. Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Du W; Simon MS Breast Cancer Res Treat; 2005 Jun; 91(3):243-8. PubMed ID: 15952057 [TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of breast cancer among young African American females. De Jesus MA; Fujita M; Kim KS; Goldson AL Breast Cancer Res Treat; 2003 Mar; 78(1):81-7. PubMed ID: 12611460 [TBL] [Abstract][Full Text] [Related]
38. Differential expression of HER-2/NEU receptor of invasive mammary carcinoma between Caucasian and African American patients in the Detroit metropolitan area. Correlation with overall survival and other prognostic factors. Al-Abbadi MA; Washington TA; Saleh HA; Tekyi-Mensah SE; Lucas DR; Briston CA Breast Cancer Res Treat; 2006 May; 97(1):3-8. PubMed ID: 16432664 [TBL] [Abstract][Full Text] [Related]
39. Does race predict survival for women with invasive breast cancer? Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623 [TBL] [Abstract][Full Text] [Related]
40. Race as an independent risk factor for breast cancer survival: breast cancer outcomes from the medical college of georgia tumor registry. Barcenas CH; Wells J; Chong D; French J; Looney SW; Samuel TA Clin Breast Cancer; 2010 Feb; 10(1):59-63. PubMed ID: 20133260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]